Continuing Education Activity

Antiseptics are chemical agents applied to the skin to reduce the microbial count and reduce the risk of surgical site infections (SSIs). SSIs are defined as an infection occurring at the surgical site within 30 days of the procedure and represent one of the most common complications of dermatologic surgery. Broad-spectrum antiseptics generally cover more pathogens and subsequently are some of the most popular in dermatologic surgery. Antiseptic agents in dermatologic surgery commonly include chlorhexidine, povidone-iodine, chloroxylenol, isopropyl alcohol, hexachlorophene, benzalkonium chloride, and hydrogen peroxide. They should be used for most, if not all, procedures that enter the dermis of the skin or deeper. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, and monitoring of skin antiseptics, so providers can direct patient therapy where they are indicated as part of the interprofessional team.

Objectives:

• Describe the mechanisms of action of some of the common dermal antiseptic agents.
• Review the indications for using dermal antiseptics.
• Summarize the potential adverse events of various skin antiseptic agents.
• Explain the importance of improving care coordination among the interprofessional team to enhance care delivery for patients who can benefit from dermal antiseptic agents.

Indications

Antiseptics are chemical agents applied to the skin to reduce the microbial count and the risk of surgical site infections (SSIs). SSIs are defined as an infection occurring at the surgical site within 30 days of a procedure and represent one of the most common complications of dermatologic surgery.[1] The use of antiseptics dates back to the mid-1800s when Ignaz Semmelweis noted a dramatic decrease in periportal sepsis events with appropriate handwashing techniques, later reaffirmed with Lister’s use of carbolic acid, showing improved infection control and reduction in surgical morbidity. Antiseptic agents in dermatologic surgery commonly include chlorhexidine, povidone-iodine, chloroxylenol, isopropyl alcohol, hexachlorophene, benzalkonium chloride, and hydrogen peroxide. They should be used for most, if not all, procedures that enter the dermis of the skin or deeper.[2]

Mechanism of Action

Each antiseptic possesses a specific mechanism of action, the spectrum of microbes targeted, and a side-effect profile that the surgeon should carefully weigh before selecting the agent for the procedure. Other factors to consider when selecting an optimal surgical scrub include the patient's underlying health status, the expected extent of surgery, the anatomic location of the tumor, and the planned reconstruction. Particularly related to the skin, the most common pathogens implicated in SSIs are Staphylococcus aureus, followed by other gram-positive bacteria, including coagulase-negative Staphylococcus, Enterococcus, and group A Streptococci. Other implicated bacteria are gram-negative rods, particularly Escherichia coli and Pseudomonas. Broad-spectrum antiseptics generally cover more pathogens and subsequently are some of the most popular in dermatologic surgery.[3]

Chlorhexidine

Chlorhexidine is a positively charged biguanide at physiologic pH that binds to bacteria's negatively charged cell walls, disrupting microbial cell membranes and precipitation of cell contents. At low concentrations, it is bacteriostatic, but at higher concentrations, it is bactericidal. Chlorhexidine displays a wide range of coverage, including gram-positive and gram-negative bacteria, fungi, enveloped viruses, and Mycobacterial tuberculosis. Advantages include its broad-spectrum, fast onset of action, and excellent sustained/residual activity after being wiped from the field via binding to the stratum corneum. It is an extensively used antiseptic in dentistry but at a much lower concentration (concentrations of 0.12% to 0.2% are recommended).[4]

Povidone-Iodine

Povidone-iodine is a complex of povidone, hydrogen iodide, and elemental iodine. It is thought to act via iodination (a form of halogenation) to oxidize lipids of the cell membrane and form salts with microbial proteins. Povidone-iodine is a broad-coverage antiseptic with microbicidal activity against gram-positive and gram-negative bacteria (including spores and M. tuberculosis), fungi, viruses, and protozoa. Additionally, this antimicrobial acts rapidly after application to the skin but has minimal residual activity, unlike chlorhexidine. In one study, as a facial antiseptic, it was considered a safer alternative to chlorhexidine.[5]

Chloroxylenol

Chloroxylenol is a halophenol that is thought to act by microbial cell wall disruption and inactivation of cellular enzymes. It is likely bactericidal with broad coverage of gram-positive and gram-negative bacteria but less activity against M. tuberculosis, fungi, and viruses. Chloroxylenol is fairly slow-acting and has a minimal residual effect; despite this, it has shown a similar incidence of SSIs as chlorhexidine in a recent study.

Isopropyl Alcohol

Isopropyl alcohol is hydrophilic alcohol that likely causes membrane damage and denatures proteins needed for microbial metabolism and growth. Isopropyl alcohol is typically mixed with water because the microbial activity is greatest in a 60% to 90% solution rather than in the pure form or lower concentrations. Generally, alcohol solutions are thought to have most of their activity against gram-positive bacteria (bactericidal) but may have minor activity against some viruses and fungi. While one of the weaker cleansing agents with minimal residual activity, it has the fastest onset of action of antiseptics.

Hexachlorophene

Hexachlorophene is a bisphenol compound that primarily acts by inhibiting the membrane-bound portion of the electron transport chain and disrupting microbial cell membranes. At concentrations used in skin-cleansing agents, it is bacteriostatic and is primarily only active against gram-positive cocci, with little activity against gram-negative organisms and no fungal coverage. Hexachlorophene has the advantage of having a residual activity for several hours after use and gradually reduces bacterial counts after multiple uses (cumulative effect). Newer agents with broader antimicrobial coverage and fewer side effects have largely replaced hexachlorophene as a surgical scrub.

Benzalkonium Chloride

Benzalkonium chloride is a quaternary ammonium detergent (also called a cationic surfactant) that acts by irreversibly binding to phospholipids and proteins of the membrane, disrupting the cell membrane. It acts as a bactericide against many gram-positive and gram-negative bacteria but has inconsistent coverage against fungi, viruses, and mycobacteria. The advantages of benzalkonium are its stability and ability to be applied with a low incidence of irritant contact dermatitis. Like hexachlorophene, benzalkonium has been replaced by antiseptics with better antimicrobial coverage.

Hydrogen Peroxide

Hydrogen peroxide is the simplest peroxide that forms highly reactive free radicals (hydroxyl radicals) that attack and oxidize essential cell components, including lipids, proteins, and nucleic acids. Although generally better against gram-positive bacteria, hydrogen peroxide also has a microbicidal effect on gram-negative bacteria, bacterial spores, fungi, and viruses with higher concentrations and longer contact times. In addition to its being a broad-spectrum agent, it has a rapid onset of action and low cost, which made it an attractive option in the past. While a common at-home remedy, the evidence argues against routine use as a surgical scrub or cleansing agent due to known cytotoxicity to keratinocytes.[6]

Administration

All of the discussed antiseptics are administered topically onto the skin surface. However, the application may differ depending on the antiseptic, concentration, and/or formulation. The two most widely administered antiseptic surgical scrub agents in dermatologic surgery are chlorhexidine and povidone-iodine.

Chlorhexidine-based scrubs are generally composed of 0.5% to 4% chlorhexidine in alcohol or aqueous base typically combined with detergent. Recent evidence suggests that it provides a bactericidal activity for 24 hours after a 2-minute application, making it a useful antiseptic for anticipated long procedures. However, as chlorhexidine can cause irreversible keratitis and middle ear ototoxicity (with sensorineural deafness), topical administration is relatively contraindicated for skin preparation involving or adjacent to the eye and conchal bowl.[5] 

Chloroxylenol 3% surgical scrub solution may be safely substituted and used for these areas. Chlorhexidine gluconate (CHG) is a commonly used antiseptic recommended by the Centers for Disease Control for skin cleansing before central venous catheter insertion in adults and children. Current guidelines do not recommend using CHG as an antiseptic in neonates due to a lack of sufficient safety data in premature infants. However, chlorhexidine is commonly used worldwide for off-label indications in neonatal intensive care units (NICU).[7]

Povidone-iodine scrubs are composed of 7.5% to 10.0% povidone-iodine, typically in an aqueous or alcohol base, and are occasionally combined with detergent. The scrub is painted on a clean skin surface and allowed to dry. The product must dry to be bactericidal with a preferred minimum of 2 minutes drying time, although the latter can vary depending on the product used as the scrub. Clinicians can safely use povidone-iodine aqueous scrubs near the eye and conchal bowl.

Given the advantages of chlorhexidine and povidone-iodine, other antiseptics are used less often or are primarily historical in dermatologic surgery. Briefly, isopropyl alcohol comes as a solution and is often used as a swab to cleanse the skin before a biopsy. Hexachlorophene scrub is an emulsion, while benzalkonium and hydrogen peroxide are both solutions. All are primarily historical with regards to antisepsis in dermatologic surgery.[8][9]

Adverse Effects

While generally tolerated well, adverse effects of antiseptic agents should be carefully weighed before selection to avoid unwanted complications.

Chlorhexidine can cause permanent keratitis, conjunctivitis, and permanent sensorineural deafness (entrance to the middle ear via hole/tear of the tympanic membrane). Chronic use can cause irritant contact dermatitis, and it is reportedly a rare contact allergen.[5][10]

Povidone-iodine can stain the skin, hair, and clothing. Severe irritant contact dermatitis can be invoked when left on the skin for prolonged periods. It is a known contact allergen that can cross-react with iodides in medications and radiopaque iodine. Microbicidal activity is lost when povidone-iodine comes into contact with blood or sputum. There are also reports of neonatal hypothyroidism with chronic maternal use via percutaneous absorption of the iodides, causing a Wolff-Chaikoff effect in newborns.[11]

Isopropyl alcohol can induce irritant contact dermatitis and is inflammable in the setting of electrocautery.

Hexachlorophene was largely removed from the market after it was linked to the deaths of multiple people via neurotoxicity and brain damage. Additionally, percutaneous absorption can also cause teratogenic effects in the fetuses of pregnant women.

Benzalkonium chloride can cause ocular toxicity and allergic contact dermatitis. While generally considered less irritating to tissues, it has also been shown to cause irritant contact dermatitis with prolonged skin exposure. Anionic compounds such as soap rapidly inactivate benzalkonium chloride.[12][13]

Contact allergy to chloroxylenol is increasingly becoming a recognized problem with its increased prevalence as a product preservative, in addition to its known irritant effects.[14]

Hydrogen peroxide is cytotoxic to keratinocytes in culture and presumably can impede the reepithelialization of wounds. In addition, it has a bleaching action that can whiten skin, hair, nails, and clothes.

Contraindications

Chlorhexidine may cause a severe allergic reaction. Symptoms may include wheezing, rash, facial swelling, and anaphylactic shock. Use is contraindicated in patients with a history of allergy to chlorhexidine.[15][16]

Povidone-iodine in individuals known to be allergic to iodine or product ingredients is contraindicated.

Isopropyl alcohol: In June 2020, the FDA issued warnings about methanol or 1-propanol contaminated hand sanitizer brands. Exposure to methanol, including dermally, can cause kidney damage, blindness, and death. Exposure to 1-propanol can cause severe acidosis and death. Chronic exposure may be more likely due to increased hand sanitizer use in 2020. In addition, FDA is warning that symptoms such as dizziness, nausea, headache, and nausea may occur after using alcohol-based hand sanitizers, likely due to breathing in the vapors. Hence always use hand sanitizer in a well-ventilated area.[17]

Hexachlorophene: The Code of Federal Regulations (CFR-21) FDA (Revised 2022) states that hexachlorophene is contraindicated on burned or denuded skin or mucous membranes and as an agent for prophylactic total body bathing. Additionally, FDA noted that although hexachlorophene is a useful bacteriostatic agent, safety concerns have been reported, such as Letterer–Siwe disease, neurotoxicity, and death. Hence, hexachlorophene-containing products will be considered misbranded and subject to regulatory proceedings.

Clinical Studies and regulatory agencies, including the FDA and EMA, agree that benzalkonium chloride is not innocuous, even when used in small concentrations.[18]

Toxicity

Chlorhexidine Gluconate: According to product labeling, chlorhexidine gluconate (4%) may cause serious injury if placed or kept in the eye during surgical procedures or cause deafness when instilled in the middle ear through perforated eardrums. In case of accidental exposure, wash the contact area thoroughly with water. 

Povidone-iodine: Allergic contact dermatitis has been reported with exposure to povidone-iodine.[19]

Hexachlorophene: The Key Potentially Inappropriate Drugs in Pediatrics (KIDs) List includes hexachlorophene because of strong evidence of neurotoxicity.[20]

Isopropyl Alcohol: The significant features of severe poisoning with isopropyl alcohol are CNS, respiratory depression, and circulatory collapse. The most common metabolic effects are an increased osmol gap, ketonemia, and ketonuria. Diagnosis is confirmed based on the patient's history, clinical presentation, and laboratory investigations. Supportive care is the mainstay of management, emphasizing respiratory and cardiovascular support. Hemodialysis enhances the elimination of isopropyl alcohol and should be considered in severe poisoning.[21]

Enhancing Healthcare Team Outcomes

Antiseptic agents in dermatologic surgery commonly include chlorhexidine, povidone-iodine, chloroxylenol, isopropyl alcohol, hexachlorophene, benzalkonium chloride, and hydrogen peroxide. All interprofessional healthcare team members should be familiar with skin antiseptics as essential to preventing SSIs. Cleaning wounds, preparing skin for incisional procedures, dressing wounds, or post-surgical wounds appropriately involves an interprofessional team approach of nurses and clinicians to achieve the best results. 

In 2013, FDA requested label changes and single-use packaging for OTC topical antiseptic products to reduce the risk of infection. Topical antiseptics are safe and effective agents for patient preoperative or preinjection skin preparation when appropriately used. To decrease the odds of patient infection, ensure these products are used according to the recommendations on the label. Topical antiseptics packaged in single-use containers intended for preoperative use should only be applied at one time to one patient. Nurses should ensure that applicators and unused solutions must be discarded after an individual use. Topical antiseptic agents must not be diluted after opening. Consider topical antiseptics as a potential source of infection when deciding the cause of postoperative infections.[22]

In 2017 FDA, issued a rule specifying that particular active ingredients used in over-the-counter antiseptics intended for use by healthcare professionals in a hospital environment or other healthcare situations outside the hospital are not commonly recognized as safe and effective (GRAS/GRAE).[23] After reviewing the previous efficacy and safety data of commonly used antiseptics, an innovative approach was needed. This innovative approach, in turn, would reduce the risk of a serious allergic reaction, enhance clinical efficacy, and reduce the risk of irritation of current perioperative antiseptics. Hence a phase 3 trial was carried out. It demonstrated that a combination of 2% chlorhexidine and 70% isopropyl alcohol preparation was efficacious in significantly diminishing the microbial burden without any major adverse events.[24] [Level 5]

When using topical antiseptics, all healthcare professionals should carefully choose the agent based on antiseptic coverage, the expected extent of surgery, the anatomic location of the tumor,  the planned reconstruction, and the patient's clinical needs. Open communication and collaborative work of surgeons, other clinical staff (MDs, DOs, NPs, and PAs), nursing staff, and pharmacists provide the safe and effective use of antiseptic agents for better treatment outcomes.

Review Questions

• Access free multiple choice questions on this topic.
• Comment on this article.

References

1.

Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008 Nov;70 Suppl 2:3-10. [PubMed: 19022115]

2.

Echols K, Graves M, LeBlanc KG, Marzolf S, Yount A. Role of antiseptics in the prevention of surgical site infections. Dermatol Surg. 2015 Jun;41(6):667-76. [PubMed: 25984901]

3.

Maris P. Modes of action of disinfectants. Rev Sci Tech. 1995 Mar;14(1):47-55. [PubMed: 7548971]

4.

Poppolo Deus F, Ouanounou A. Chlorhexidine in Dentistry: Pharmacology, Uses, and Adverse Effects. Int Dent J. 2022 Jun;72(3):269-277. [PMC free article: PMC9275362] [PubMed: 35287956]

5.

Steinsapir KD, Woodward JA. Chlorhexidine Keratitis: Safety of Chlorhexidine as a Facial Antiseptic. Dermatol Surg. 2017 Jan;43(1):1-6. [PubMed: 27399954]

6.

McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev. 1999 Jan;12(1):147-79. [PMC free article: PMC88911] [PubMed: 9880479]

7.

Vanzi V, Pitaro R. Skin Injuries and Chlorhexidine Gluconate-Based Antisepsis in Early Premature Infants: A Case Report and Review of the Literature. J Perinat Neonatal Nurs. 2018 Oct/Dec;32(4):341-350. [PubMed: 29782437]

8.

Alam M, Cohen JL, Petersen B, Schlessinger DI, Weil A, Iyengar S, Poon E. Association of Different Surgical Sterile Prep Solutions With Infection Risk After Cutaneous Surgery of the Head and Neck. JAMA Dermatol. 2017 Aug 01;153(8):830-831. [PMC free article: PMC5817601] [PubMed: 28538967]

9.

Darouiche RO, Wall MJ, Itani KM, Otterson MF, Webb AL, Carrick MM, Miller HJ, Awad SS, Crosby CT, Mosier MC, Alsharif A, Berger DH. Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med. 2010 Jan 07;362(1):18-26. [PubMed: 20054046]

10.

Opstrup MS, Johansen JD, Zachariae C, Garvey LH. Contact allergy to chlorhexidine in a tertiary dermatology clinic in Denmark. Contact Dermatitis. 2016 Jan;74(1):29-36. [PubMed: 26560642]

11.

Lachapelle JM. Allergic contact dermatitis from povidone-iodine: a re-evaluation study. Contact Dermatitis. 2005 Jan;52(1):9-10. [PubMed: 15701122]

12.

Hann S, Hughes TM, Stone NM. Flexural allergic contact dermatitis to benzalkonium chloride in antiseptic bath oil. Br J Dermatol. 2007 Oct;157(4):795-8. [PubMed: 17714561]

13.

Baudouin C, Labbé A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010 Jul;29(4):312-34. [PubMed: 20302969]

14.

Wilson M, Mowad C. Chloroxylenol. Dermatitis. 2007 Jun;18(2):120-1. [PubMed: 17498419]

15.

Beaudouin E, Kanny G, Morisset M, Renaudin JM, Mertes M, Laxenaire MC, Mouton C, Jacson F, Moneret-Vautrin DA. Immediate hypersensitivity to chlorhexidine: literature review. Eur Ann Allergy Clin Immunol. 2004 Apr;36(4):123-6. [PubMed: 15180352]

16.

Chen P, Huda W, Levy N. Chlorhexidine anaphylaxis: implications for post-resuscitation management. Anaesthesia. 2016 Feb;71(2):242-3. [PubMed: 26750419]

17.

McCulley L, Cheng C, Mentari E, Diak IL, Michele T. Alcohol-based hand sanitizer exposures and effects on young children in the U.S. during the COVID-19 pandemic. Clin Toxicol (Phila). 2021 Apr;59(4):355-356. [PMC free article: PMC7910312] [PubMed: 32852232]

18.

Merchel Piovesan Pereira B, Tagkopoulos I. Benzalkonium Chlorides: Uses, Regulatory Status, and Microbial Resistance. Appl Environ Microbiol. 2019 Jul 01;85(13) [PMC free article: PMC6581159] [PubMed: 31028024]

19.

Vanhoutte C, Goossens A, Gilissen L, Huygens S, Vital-Durand D, Dendooven E, Aerts O. Concomitant contact-allergic reactions to iodopropynyl butylcarbamate and iodine. Contact Dermatitis. 2019 Jul;81(1):17-23. [PubMed: 30663063]

20.

Meyers RS, Thackray J, Matson KL, McPherson C, Lubsch L, Hellinga RC, Hoff DS. Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List. J Pediatr Pharmacol Ther. 2020;25(3):175-191. [PMC free article: PMC7134587] [PubMed: 32265601]

21.

Slaughter RJ, Mason RW, Beasley DM, Vale JA, Schep LJ. Isopropanol poisoning. Clin Toxicol (Phila). 2014 Jun;52(5):470-8. [PubMed: 24815348]

22.

FDA drug safety communication: FDA requests label changes and single-use packaging for some over-the-counter topical antiseptic products to decrease risk of infection. Clin Infect Dis. 2014 Feb;58(3):i-ii. [PubMed: 24571007]

23.

Food and Drug Administration, HHS. Safety and Effectiveness of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final rule. Fed Regist. 2017 Dec 20;82(242):60474-503. [PubMed: 29260839]

24.

Edmiston CE, Lavin P, Spencer M, Borlaug G, Seabrook GR, Leaper D. Antiseptic efficacy of an innovative perioperative surgical skin preparation: A confirmatory FDA phase 3 analysis. Infect Control Hosp Epidemiol. 2020 Jun;41(6):653-659. [PMC free article: PMC7282856] [PubMed: 32131912]

Disclosure: Robert Bednarek declares no relevant financial relationships with ineligible companies.

Disclosure: Ali Nassereddin declares no relevant financial relationships with ineligible companies.

Disclosure: Michael Ramsey declares no relevant financial relationships with ineligible companies.